Sulfonylurea Receptor 1 in Central Nervous System Injury: An Updated Review

Autor: Sandra Mihaljevic, Juan Sahuquillo, Raj K. Narayan, Anupama Rani, Shashvat M. Desai, W. Taylor Kimberly, Sudhanshu P. Raikwar, J. Claude Hemphill, Patrick M. Kochanek, Joshua S Catapano, Ruchira M. Jha, Giuseppe Citerio, J. Marc Simard, Ethan Winkler, Kevin N. Sheth, Amanda Munoz-Casabella
Přispěvatelé: Institut Català de la Salut, [Jha RM] Department of Neurology, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. Department of Translational Neuroscience, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. Department of Neurosurgery, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [Rani A, Raikwar S, Mihaljevic S, Munoz-Casabella A] Department of Translational Neuroscience, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [Desai SM] Department of Neurology, Barrow Neurological Institute and St. Joseph’s Hospital and Medical Center, Phoenix, AZ 85013, USA. [Sahuquillo J] Unitat de Recerca en Neurotraumatologia i Neurocirurgia (UNINN), Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Unitat de Recerca en Neurotraumatologia i Neurocirurgia, Universitat Autònoma de Barcelona, Bellaterra, Spain. Servei de Neurocirurgia, Vall d’Hebron Hospital Universitari, Barcelona, Spain, Vall d'Hebron Barcelona Hospital Campus, Jha, R, Rani, A, Desai, S, Raikwar, S, Mihaljevic, S, Munoz-Casabella, A, Kochanek, P, Catapano, J, Winkler, E, Citerio, G, Hemphill, J, Kimberly, W, Narayan, R, Sahuquillo, J, Sheth, K, Simard, J
Jazyk: angličtina
Rok vydání: 2021
Předmět:
Sistema nerviós central - Malalties
Review
enfermedades del sistema nervioso::enfermedades del sistema nervioso central [ENFERMEDADES]
Sulfonylurea Receptors
Bioinformatics
Central Nervous System Diseases
Biology (General)
Stroke
Spinal cord injury
Spectroscopy
Otros calificadores::Otros calificadores::/metabolismo [Otros calificadores]
Amino Acids
Peptides
and Proteins::Proteins::Carrier Proteins::Membrane Transport Proteins::Ion Channels::Potassium Channels::Potassium Channels
Inwardly Rectifying::KATP Channels::Sulfonylurea Receptors [CHEMICALS AND DRUGS]

traumatic brain injury
Other subheadings::Other subheadings::/metabolism [Other subheadings]
General Medicine
stroke
Computer Science Applications
Clinical trial
Chemistry
medicine.anatomical_structure
aminoácidos
péptidos y proteínas::proteínas::proteínas transportadoras::proteínas de transporte de membrana::canales iónicos::canales del potasio::canales del potasio de correción hacia el interior::canales KATP::receptores de sulfonilureas [COMPUESTOS QUÍMICOS Y DROGAS]

Subarachnoid hemorrhage
Traumatic brain injury
TRPM4
QH301-705.5
Central nervous system
Nervous System Diseases::Central Nervous System Diseases [DISEASES]
Catalysis
Inorganic Chemistry
sulfonylurea receptor
medicine
Animals
Humans
Physical and Theoretical Chemistry
Molecular Biology
QD1-999
Canals de potassi - Metabolisme
Intracerebral hemorrhage
clinical trials
business.industry
Multiple sclerosis
Organic Chemistry
medicine.disease
Brain Injuries
Sulfonylurea receptor
cellular swelling
business
edema
SUR 1
Zdroj: International Journal of Molecular Sciences, Vol 22, Iss 11899, p 11899 (2021)
International Journal of Molecular Sciences
Scientia
International Journal of Molecular Sciences, vol 22, iss 21
ISSN: 1661-6596
1422-0067
Popis: Hinchazón celular; Edema; Traumatismo cerebral Cellular swelling; Edema; Traumatic brain injury Inflor cel·lular; Edema; Traumatisme cerebral Sulfonylurea receptor 1 (SUR1) is a member of the adenosine triphosphate (ATP)-binding cassette (ABC) protein superfamily, encoded by Abcc8, and is recognized as a key mediator of central nervous system (CNS) cellular swelling via the transient receptor potential melastatin 4 (TRPM4) channel. Discovered approximately 20 years ago, this channel is normally absent in the CNS but is transcriptionally upregulated after CNS injury. A comprehensive review on the pathophysiology and role of SUR1 in the CNS was published in 2012. Since then, the breadth and depth of understanding of the involvement of this channel in secondary injury has undergone exponential growth: SUR1-TRPM4 inhibition has been shown to decrease cerebral edema and hemorrhage progression in multiple preclinical models as well as in early clinical studies across a range of CNS diseases including ischemic stroke, traumatic brain injury, cardiac arrest, subarachnoid hemorrhage, spinal cord injury, intracerebral hemorrhage, multiple sclerosis, encephalitis, neuromalignancies, pain, liver failure, status epilepticus, retinopathies and HIV-associated neurocognitive disorder. Given these substantial developments, combined with the timeliness of ongoing clinical trials of SUR1 inhibition, now, another decade later, we review advances pertaining to SUR1-TRPM4 pathobiology in this spectrum of CNS disease—providing an overview of the journey from patch-clamp experiments to phase III trials. No funding directly supported the writing of this review. R.M.J. is supported by grants from the National Institute of Neurological Disorders and Stroke (NINDS) (K23NS101036; R01NS115815), and the Barrow Neurological Foundation. J.M.S. is supported by grants from the Department of Veterans Affairs (I01RX003060; 1I01BX004652), the Department of Defense (SC170199), the National Heart, Lung and Blood Institute (R01HL082517) and the NINDS (R01NS102589; R01NS105633).
Databáze: OpenAIRE